The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs)

MOTIVATION Neurodegenerative disorders (NDDs) are progressive and fatal disorders, which are commonly characterized by the intracellular or extracellular presence of abnormal protein aggregates. The identification and verification of proteins interacting with causative gene products are effective ways to understand their physiological and pathological functions. The objective of this research is to better understand common molecular pathogenic mechanisms in NDDs by employing protein-protein interaction networks, the domain characteristics commonly identified in NDDs and correlation among NDDs based on domain information. RESULTS By reviewing published literatures in PubMed, we created pathway maps in Kyoto Encyclopedia of Genes and Genomes (KEGG) for the protein-protein interactions in six NDDs: Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), dentatorubral-pallidoluysian atrophy (DRPLA) and prion disease (PRION). We also collected data on 201 interacting proteins and 13 compounds with 282 interactions from the literature. We found 19 proteins common to these six NDDs. These common proteins were mainly involved in the apoptosis and MAPK signaling pathways. We expanded the interaction network by adding protein interaction data from the Human Protein Reference Database and gene expression data from the Human Gene Expression Index Database. We then carried out domain analysis on the extended network and found the characteristic domains, such as 14-3-3 protein, phosphotyrosine interaction domain and caspase domain, for the common proteins. Moreover, we found a relatively high correlation between AD, PD, HD and PRION, but not ALS or DRPLA, in terms of the protein domain distributions. AVAILABILITY http://www.genome.jp/kegg/pathway/hsa/hsa01510.html (KEGG pathway maps for NDDs).

[1]  G. Stephanopoulos,et al.  A compendium of gene expression in normal human tissues. , 2001, Physiological genomics.

[2]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[3]  D. Bredesen,et al.  Misfolded proteins, endoplasmic reticulum stress and neurodegeneration. , 2004, Current opinion in cell biology.

[4]  F. Hartl,et al.  Roles of molecular chaperones in protein misfolding diseases. , 2004, Seminars in cell & developmental biology.

[5]  Andrew F Hill,et al.  Delineating common molecular mechanisms in Alzheimer's and prion diseases. , 2006, Trends in biochemical sciences.

[6]  Pier Andrea Serra,et al.  Glucocorticoid receptor–nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia–neuron interactions , 2005, Brain Research Reviews.

[7]  P Choi,et al.  alpha-Synuclein shares physical and functional homology with 14-3-3 proteins. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[8]  F. Giorgini,et al.  Connecting the dots in Huntington's disease with protein interaction networks , 2005, Genome Biology.

[9]  Robert D. Finn,et al.  Pfam: clans, web tools and services , 2005, Nucleic Acids Res..

[10]  B. Margolis,et al.  The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein , 1996, Molecular and cellular biology.

[11]  Christopher A. Ross,et al.  Atrophin-1, the DRPLA Gene Product, Interacts with Two Families of WW Domain-Containing Proteins , 1998, Molecular and Cellular Neuroscience.

[12]  Zheng Jing,et al.  Focal adhesions regulate Abeta signaling and cell death in Alzheimer's disease. , 2007, Biochimica et biophysica acta.

[13]  Chi V Dang,et al.  Multifaceted roles of glycolytic enzymes. , 2005, Trends in biochemical sciences.

[14]  Peter M Mathisen,et al.  Gene discovery and validation for neurodegenerative diseases. , 2003, Drug discovery today.

[15]  Hanno Steen,et al.  Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.

[16]  C. MacKintosh,et al.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. , 2004, The Biochemical journal.

[17]  Peter M. Haverty,et al.  HugeIndex: a database with visualization tools for high-density oligonucleotide array data from normal human tissues , 2002, Nucleic Acids Res..

[18]  D. Morrison,et al.  Unlocking the code of 14-3-3 , 2004, Journal of Cell Science.

[19]  S. Lipton,et al.  Molecular pathways to neurodegeneration , 2004, Nature Medicine.

[20]  A Caricasole,et al.  Two Sides of the Same Coin: Wnt Signaling in Neurodegeneration and Neuro-Oncology , 2005, Bioscience reports.

[21]  Sean R. Eddy,et al.  Profile hidden Markov models , 1998, Bioinform..

[22]  C. Ross,et al.  Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.

[23]  D. Chuang,et al.  Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. , 2005, Annual review of pharmacology and toxicology.

[24]  Jennifer L Mazzola,et al.  Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? , 2002, Neurotoxicology.

[25]  L. Petrucelli,et al.  α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins , 1999, The Journal of Neuroscience.

[26]  H. Lehrach,et al.  A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.

[27]  D. Butterfield,et al.  REVIEW: Pin1 in Alzheimer's disease , 2006, Journal of neurochemistry.

[28]  Takashi Kudo,et al.  The Unfolded Protein Response Is Involved in the Pathology of Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.

[29]  Marius Sudol,et al.  WW and SH3 domains, two different scaffolds to recognize proline‐rich ligands , 2002, FEBS letters.

[30]  I. Vincent,et al.  The cell cycle and human neurodegenerative disease. , 2003, Progress in cell cycle research.

[31]  Asma Nusrat,et al.  Association of BAP31 with CD11b/CD18 , 2004, Journal of Biological Chemistry.

[32]  P. Lantos,et al.  Overlap between neurodegenerative disorders , 2005, Neuropathology : official journal of the Japanese Society of Neuropathology.

[33]  Nobutaka Hirokawa,et al.  Molecular motors in neuronal development, intracellular transport and diseases , 2004, Current Opinion in Neurobiology.

[34]  Kiyoko F. Aoki-Kinoshita,et al.  From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..

[35]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.